1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. BioVentrix Acquires MateraCor

M&A Deal Summary

BioVentrix Acquires MateraCor

On January 27, 2022, BioVentrix acquired medical products company MateraCor

Acquisition Highlights
  • This is BioVentrix’s 1st transaction in the Medical Products sector.
  • This is BioVentrix’s 1st transaction in the United States.
  • This is BioVentrix’s 1st transaction in California.

M&A Deal Summary
Date 2022-01-27
Target MateraCor
Sector Medical Products
Buyer(s) BioVentrix
Deal Type Add-on Acquisition

Target

MateraCor

Aliso Viejo, California, United States
MateraCor is a company focused on preventing progression of, and reversing, heart failure through the use of injectable alginate-based hydrogel. MateraCor is based in Aliso Viejo, California.

Search 214,877 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

BioVentrix

San Ramon, California, United States
Category Company
Sector Medical Products
DESCRIPTION

BioVentrix, Inc. is a medical device company. BioVentrix treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches. BioVentrix is based in San Ramon, California.

DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: California M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2022 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal